definiens: mean any and all inventio ns, processes or methods which are the subject of patent applications under U.S. Patent Laws ( 35 U.S. ss . 101 et seq . ) or equivalent internation al patent laws, and the resulting granted U.S. or foreign patent, including associated Letters Patent, substitutions, re - examinations, extensions, reissue s, continuations, continuations - in - part, divisionals, Supplemental Pr otection Certificates ( SPC ) or other recognized forms of patent protection, whe ther U.S. or foreign, issued therefrom owned or controlled by RegeneRx and relat ing to Bulk Active Material, Finished Products, Joint Improvements or RegeneRx I mprovements . Patents related to Bulk Active Material at the Effective Date are r ecited in Attachment A, which is made a part hereof by reference . During the Term of this Agreement and in the event of the occurrence of RegeneRx Improvements or Joint Improvements, which may be the subject of Patents, such Patents shall b e added to Attachment A from time to time throughout the Term herein